Arcutis Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
04 mars 2024 16h00 HE
|
Arcutis Biotherapeutics, Inc.
Arcutis today announced the closing of its previously announced underwritten public offering.
Polar Power, Inc. Announces Closing of Public Offering
05 déc. 2023 17h15 HE
|
Polar Power, Inc.
Gardena, CA, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Polar Power, Inc. (Nasdaq: POLA) (“Polar Power” or the “Company”), a technology company that designs, manufactures and sells direct current, or DC,...
Save Foods, Inc. Announces Closing of Public Offering
18 août 2022 15h21 HE
|
Save Foods Inc
Neve Yarak, Israel, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Save Foods, Inc. (Nasdaq: SVFD) (FSE:80W), an agri-food tech company specializing in eco crop protection that helps to reduce food waste and...
Ballantyne Strong, Inc. Announces Closing of Public Offering
08 févr. 2021 16h15 HE
|
Ballantyne Strong, Inc.
Charlotte, NC, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Ballantyne Strong, Inc. (NYSE American: BTN) (“Ballantyne Strong” or the “Company”) today announced the closing of its previously announced public...
ProPhase Labs, Inc. Announces Closing of Public Offering
21 janv. 2021 16h30 HE
|
ProPhase Labs, Inc.
Garden City, NY, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced the closing of its previously announced...
Lixte Biotechnology Holdings, Inc. Announces Closing of Public Offering and Uplisting to Nasdaq
01 déc. 2020 12h30 HE
|
Lixte Biotechnology Holdings, Inc.
East Setauket, NY, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (“Lixte” or the “Company”) (Nasdaq: Common stock – LIXT; Warrants – LIXTW), a drug discovery company that uses...
Cancer Genetics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
02 nov. 2020 16h00 HE
|
Cancer Genetics, Inc.
Rutherford, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics” or “the Company”), a leader in drug discovery and preclinical oncology and immuno-oncology...
Celsion Corporation Announces Closing of Public Offering of Common Stock
24 juin 2020 16h15 HE
|
Celsion CORP
Lawrenceville, NJ, June 24, 2020 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced the closing of its previously announced public offering...